Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) impact on immune microenvironment in non-small cell lung cancer (NSCLC).

被引：2
|
作者：
Tang, Jie
Liu, XiaoLing
Gong, Youling
Zhu, Jiang
Huang, Meijuan
Ding, Zhenyu
Yu, Min
Tie, Yan
Li, Qiu
Wang, Yongsheng
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Dept Thorac Oncol, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Canc Ctr, Dept Thorac Canc, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21154
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21154
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancer
    Matsumoto, Yoshiya
    Sawa, Kenji
    Fukui, Mitsuru
    Oyanagi, Jun
    Izumi, Motohiro
    Ogawa, Koichi
    Suzumura, Tomohiro
    Watanabe, Tetsuya
    Kaneda, Hiroyasu
    Mitsuoka, Shigeki
    Asai, Kazuhisa
    Kimura, Tatsuo
    Yamamoto, Nobuyuki
    Koh, Yasuhiro
    Kawaguchi, Tomoya
    CANCER SCIENCE, 2019, 110 (10) : 3244 - 3254
  • [22] Changes in serum proteomic profile of non-small cell lung cancer (NSCLC) patients during therapy with epidermal growth factor receptor tirosine kinase inhibitors (EGFR-TKIs): Preliminary report
    Spreafico, A.
    Grigorieva, J.
    Cattaneo, A.
    Belli, C.
    Tsypin, M.
    Roder, H.
    Giovannini, M.
    Alessio, M.
    Gregorc, V.
    Bachi, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Tyrosine Kinase Inhibitors and Epidermal Growth Factor Receptor (EGFR) Mutations in Non-Small Cell Lung Cancer To Test or Not to Test?
    Gazdar, Adi F.
    MEDICINE, 2011, 90 (03) : 168 - 170
  • [24] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Kujtan, Lara
    Subramanian, Janakiraman
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 547 - 559
  • [25] Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    周清
    魏雪武
    高欣
    何韵婷
    杨潇蓉
    Science Foundation in China, 2019, 27 (01) : 72 - 80
  • [26] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer
    Malik, Prabhat Singh
    Jain, Deepali
    Kumar, Lalit
    ONCOLOGY, 2016, 91 : 26 - 34
  • [27] Epidermal growth factor receptor tyrosine kinase inhibitors - Application in non-small cell lung cancer
    Thomas, M
    CANCER NURSING, 2003, 26 (06) : 21S - 25S
  • [28] Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
    Hammerman, Peter S.
    Jaenne, Pasi A.
    Johnson, Bruce E.
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7502 - 7509
  • [29] Treatment of brain metastases in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations: the role of EGFR tyrosine kinase inhibitors
    Karachaliou, Niki
    Rosell, Rafael
    ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (03) : 114 - 117
  • [30] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer
    Ogunleye, Foluso
    Ibrahim, Mohammed
    Stender, Michael
    Kalemkerian, Gregory
    Jaiyesimi, Ishmael
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (01) : 16 - 25
12345